Literature DB >> 10331676

Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

J French1, M Smith, E Faught, L Brown.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331676     DOI: 10.1212/wnl.52.8.1540

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  17 in total

Review 1.  Felbamate as an add-on therapy for refractory partial epilepsy.

Authors:  Li Li Shi; JianCheng Dong; HengJian Ni; JinSong Geng; Taixiang Wu
Journal:  Cochrane Database Syst Rev       Date:  2017-07-18

2.  Randomized controlled trials and assessment of drug safety.

Authors:  David W J Clark; David M Coulter; Frank M C Besag
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 3.  Newer antiepileptic drugs: evidence based use.

Authors:  Gouri Rao Passi
Journal:  Indian J Pediatr       Date:  2014-06-25       Impact factor: 1.967

Review 4.  A risk-benefit assessment of therapies for Lennox-Gastaut syndrome.

Authors:  D Schmidt; B Bourgeois
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

Review 5.  Treating epilepsy in the elderly: safety considerations.

Authors:  S Arroyo; G Kramer
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

6.  Phenobarbital for childhood epilepsy: systematic review.

Authors:  Deb K Pal
Journal:  Paediatr Perinat Drug Ther       Date:  2006-05

Review 7.  Seizures in elderly patients with dementia: epidemiology and management.

Authors:  Mario Mendez; Gerald Lim
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 8.  NMDA receptors in clinical neurology: excitatory times ahead.

Authors:  Lorraine V Kalia; Suneil K Kalia; Michael W Salter
Journal:  Lancet Neurol       Date:  2008-08       Impact factor: 44.182

9.  Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Authors:  Andres M Kanner; Eric Ashman; David Gloss; Cynthia Harden; Blaise Bourgeois; Jocelyn F Bautista; Bassel Abou-Khalil; Evren Burakgazi-Dalkilic; Esmeralda Llanas Park; John Stern; Deborah Hirtz; Mark Nespeca; Barry Gidal; Edward Faught; Jacqueline French
Journal:  Epilepsy Curr       Date:  2018 Jul-Aug       Impact factor: 7.500

10.  Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Authors:  Andres M Kanner; Eric Ashman; David Gloss; Cynthia Harden; Blaise Bourgeois; Jocelyn F Bautista; Bassel Abou-Khalil; Evren Burakgazi-Dalkilic; Esmeralda Llanas Park; John Stern; Deborah Hirtz; Mark Nespeca; Barry Gidal; Edward Faught; Jacqueline French
Journal:  Epilepsy Curr       Date:  2018 Jul-Aug       Impact factor: 7.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.